RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates

分组1 - RxSight, Inc. reported a quarterly loss of $0.03 per share, better than the Zacks Consensus Estimate of a loss of $0.04, and improved from a loss of $0.12 per share a year ago, representing a 25% earnings surprise [1] - The company posted revenues of $37.9 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 0.01%, and showing an increase from $29.51 million year-over-year [2] - RxSight has surpassed consensus EPS estimates two times over the last four quarters and topped consensus revenue estimates four times during the same period [2] 分组2 - The stock has lost approximately 59.4% since the beginning of the year, compared to a decline of 4.7% in the S&P 500 [3] - The current consensus EPS estimate for the coming quarter is $0.01 on revenues of $42.48 million, with a breakeven estimate of $174.01 million for the current fiscal year [7] - The Zacks Industry Rank for Medical - Instruments is in the top 35% of over 250 Zacks industries, indicating a favorable outlook for the industry [8]